Stock News Update: Citius Pharmaceuticals (CTXR)

Citius Pharmaceuticals (NASDAQ: CTXR) spotted trading -66.76% off 52-week high price. On the other end, the stock has been noted 40.34% away from the low price over the last 52-weeks. The stock changed 0.96% to recent value of $0.6. The stock transacted 43936 shares during most recent day however it has an average volume of 158.42K shares. The company has 22.65M of outstanding shares and 9.77M shares were floated in the market.

Citius Pharmaceuticals (NASDAQ: CTXR), a specialty pharmaceutical company focused on developing adjunctive cancer care and critical care drug products, announced today that the Company will present at the 5th Annual Dawson James Small Cap Growth Conference on Tuesday, Oct 29, 2019 at 4:30-4:50 PM ET in Track 2 – Preserve Ballroom B. The conference is being held at the Wyndham Grand Hotel in Jupiter, Florida on October 28-29, 2019.

Mr. Leonard Mazur, Chairman of Citius Pharmaceuticals will be delivering an overview of the company including recent highlights as well as answering questions from investors. Citius Pharmaceuticals will also be available for one-on-one meetings.

Its earnings per share (EPS) expected to touch remained 38.30% for this year .

According to the most recent quarter its current ratio was 1.1 that represents company’s ability to meet its current financial obligations. The price moved ahead of -7.76% from the mean of 20 days, -32.61% from mean of 50 days SMA and performed -45.01% from mean of 200 days price. Company’s performance for the week was 4.39%, -22.72% for month and YTD performance remained -42.78%.

Leave a Reply

Your email address will not be published. Required fields are marked *